The reduction in price target by RBC Capital, while maintaining a Sector Perform rating, suggests a cautious outlook on Nevro's stock. This adjustment reflects analyst Shagun Singh's revised expectations for the company's future performance, potentially due to underlying challenges or slower growth prospects. Such a move is likely to influence investor sentiment negatively in the short term, leading to a possible decrease in stock price.